Retrieved from Xenaki, N., Bacopoulou, F., Kokkinos, A., et al
The correlation between the anti-inflammatory properties of GLP-1RA and clinical outcomes need more research
Hypoglycemia risk with the combination is lower than with insulin intensification strategies like adding mealtime insulin
Recent clinical studies suggest that Zepbound (tirzepatide) may have a higher success rate in promoting weight loss compared to Wegovy ( semaglutide GLP-1 )
Heres what you need to know: Manufacturer Savings Programs Novo Nordisk (makes Wegovy, Ozempic, and Saxenda) offers savings cards that can reduce copays to as low as $25 per month for eligible patients with commercial insurance These programs have specific eligibility requirements and typically exclude Medicare/Medicaid patients Your doctors office can help you determine eligibility and apply Prior Authorization Tips If your insurance requires prior authorization, be patient
2000]Review Hypoglycemia During Therapy of Diabetes